English
简体中文
Total: £ 56.28
Published Date: 2024-07-18 | Pages: 89 | Tables: 156 | Medical Care
Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
The global Hypertension RDN Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hypertension RDN Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hypertension RDN Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Hypertension RDN Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Hypertension RDN Therapy include Medtronic, ReCor Medical, Sonivies, Covidien, Boston Scientific, Johnson & Johnson, Terumo Corporation, Angiocare and Shanghai Golden Leaf Med Tec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hypertension RDN Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension RDN Therapy.
Report Scope
The Hypertension RDN Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hypertension RDN Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hypertension RDN Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech
Segment by Type
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypertension RDN Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension RDN Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 r-Renal Denervation(rRDN)
1.2.3 u-Renal Denervation(uRDN)
1.3 Market by Application
1.3.1 Global Hypertension RDN Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension RDN Therapy Market Perspective (2019-2030)
2.2 Hypertension RDN Therapy Growth Trends by Region
2.2.1 Global Hypertension RDN Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hypertension RDN Therapy Historic Market Size by Region (2019-2024)
2.2.3 Hypertension RDN Therapy Forecasted Market Size by Region (2025-2030)
2.3 Hypertension RDN Therapy Market Dynamics
2.3.1 Hypertension RDN Therapy Industry Trends
2.3.2 Hypertension RDN Therapy Market Drivers
2.3.3 Hypertension RDN Therapy Market Challenges
2.3.4 Hypertension RDN Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypertension RDN Therapy Players by Revenue
3.1.1 Global Top Hypertension RDN Therapy Players by Revenue (2019-2024)
3.1.2 Global Hypertension RDN Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Hypertension RDN Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypertension RDN Therapy Revenue
3.4 Global Hypertension RDN Therapy Market Concentration Ratio
3.4.1 Global Hypertension RDN Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension RDN Therapy Revenue in 2023
3.5 Hypertension RDN Therapy Key Players Head office and Area Served
3.6 Key Players Hypertension RDN Therapy Product Solution and Service
3.7 Date of Enter into Hypertension RDN Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension RDN Therapy Breakdown Data by Type
4.1 Global Hypertension RDN Therapy Historic Market Size by Type (2019-2024)
4.2 Global Hypertension RDN Therapy Forecasted Market Size by Type (2025-2030)
5 Hypertension RDN Therapy Breakdown Data by Application
5.1 Global Hypertension RDN Therapy Historic Market Size by Application (2019-2024)
5.2 Global Hypertension RDN Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hypertension RDN Therapy Market Size (2019-2030)
6.2 North America Hypertension RDN Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hypertension RDN Therapy Market Size by Country (2019-2024)
6.4 North America Hypertension RDN Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hypertension RDN Therapy Market Size (2019-2030)
7.2 Europe Hypertension RDN Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hypertension RDN Therapy Market Size by Country (2019-2024)
7.4 Europe Hypertension RDN Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypertension RDN Therapy Market Size (2019-2030)
8.2 Asia-Pacific Hypertension RDN Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hypertension RDN Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Hypertension RDN Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hypertension RDN Therapy Market Size (2019-2030)
9.2 Latin America Hypertension RDN Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hypertension RDN Therapy Market Size by Country (2019-2024)
9.4 Latin America Hypertension RDN Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypertension RDN Therapy Market Size (2019-2030)
10.2 Middle East & Africa Hypertension RDN Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hypertension RDN Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Hypertension RDN Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Hypertension RDN Therapy Introduction
11.1.4 Medtronic Revenue in Hypertension RDN Therapy Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 ReCor Medical
11.2.1 ReCor Medical Company Detail
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Hypertension RDN Therapy Introduction
11.2.4 ReCor Medical Revenue in Hypertension RDN Therapy Business (2019-2024)
11.2.5 ReCor Medical Recent Development
11.3 Sonivies
11.3.1 Sonivies Company Detail
11.3.2 Sonivies Business Overview
11.3.3 Sonivies Hypertension RDN Therapy Introduction
11.3.4 Sonivies Revenue in Hypertension RDN Therapy Business (2019-2024)
11.3.5 Sonivies Recent Development
11.4 Covidien
11.4.1 Covidien Company Detail
11.4.2 Covidien Business Overview
11.4.3 Covidien Hypertension RDN Therapy Introduction
11.4.4 Covidien Revenue in Hypertension RDN Therapy Business (2019-2024)
11.4.5 Covidien Recent Development
11.5 Boston Scientific
11.5.1 Boston Scientific Company Detail
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Hypertension RDN Therapy Introduction
11.5.4 Boston Scientific Revenue in Hypertension RDN Therapy Business (2019-2024)
11.5.5 Boston Scientific Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Hypertension RDN Therapy Introduction
11.6.4 Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Detail
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Hypertension RDN Therapy Introduction
11.7.4 Terumo Corporation Revenue in Hypertension RDN Therapy Business (2019-2024)
11.7.5 Terumo Corporation Recent Development
11.8 Angiocare
11.8.1 Angiocare Company Detail
11.8.2 Angiocare Business Overview
11.8.3 Angiocare Hypertension RDN Therapy Introduction
11.8.4 Angiocare Revenue in Hypertension RDN Therapy Business (2019-2024)
11.8.5 Angiocare Recent Development
11.9 Shanghai Golden Leaf Med Tec
11.9.1 Shanghai Golden Leaf Med Tec Company Detail
11.9.2 Shanghai Golden Leaf Med Tec Business Overview
11.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Introduction
11.9.4 Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2019-2024)
11.9.5 Shanghai Golden Leaf Med Tec Recent Development
11.10 Shanghai Bio-Heart Biological Technology
11.10.1 Shanghai Bio-Heart Biological Technology Company Detail
11.10.2 Shanghai Bio-Heart Biological Technology Business Overview
11.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Introduction
11.10.4 Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2019-2024)
11.10.5 Shanghai Bio-Heart Biological Technology Recent Development
11.11 Xinmai Medical Equipment
11.11.1 Xinmai Medical Equipment Company Detail
11.11.2 Xinmai Medical Equipment Business Overview
11.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Introduction
11.11.4 Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2019-2024)
11.11.5 Xinmai Medical Equipment Recent Development
11.12 Microport Ep Medtech
11.12.1 Microport Ep Medtech Company Detail
11.12.2 Microport Ep Medtech Business Overview
11.12.3 Microport Ep Medtech Hypertension RDN Therapy Introduction
11.12.4 Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2019-2024)
11.12.5 Microport Ep Medtech Recent Development
11.13 Cryofocus Medtech
11.13.1 Cryofocus Medtech Company Detail
11.13.2 Cryofocus Medtech Business Overview
11.13.3 Cryofocus Medtech Hypertension RDN Therapy Introduction
11.13.4 Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2019-2024)
11.13.5 Cryofocus Medtech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hypertension RDN Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of r-Renal Denervation(rRDN)
Table 3. Key Players of u-Renal Denervation(uRDN)
Table 4. Global Hypertension RDN Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Hypertension RDN Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hypertension RDN Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Hypertension RDN Therapy Market Share by Region (2019-2024)
Table 8. Global Hypertension RDN Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Hypertension RDN Therapy Market Share by Region (2025-2030)
Table 10. Hypertension RDN Therapy Market Trends
Table 11. Hypertension RDN Therapy Market Drivers
Table 12. Hypertension RDN Therapy Market Challenges
Table 13. Hypertension RDN Therapy Market Restraints
Table 14. Global Hypertension RDN Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Hypertension RDN Therapy Market Share by Players (2019-2024)
Table 16. Global Top Hypertension RDN Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2023)
Table 17. Ranking of Global Top Hypertension RDN Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Hypertension RDN Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hypertension RDN Therapy Product Solution and Service
Table 21. Date of Enter into Hypertension RDN Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hypertension RDN Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Hypertension RDN Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Hypertension RDN Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Hypertension RDN Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Hypertension RDN Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Hypertension RDN Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Hypertension RDN Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Hypertension RDN Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Hypertension RDN Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Hypertension RDN Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Hypertension RDN Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Hypertension RDN Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Hypertension RDN Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Hypertension RDN Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Hypertension RDN Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Hypertension RDN Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Hypertension RDN Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Hypertension RDN Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Hypertension RDN Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Hypertension RDN Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Hypertension RDN Therapy Product
Table 49. Medtronic Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. ReCor Medical Company Detail
Table 52. ReCor Medical Business Overview
Table 53. ReCor Medical Hypertension RDN Therapy Product
Table 54. ReCor Medical Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 55. ReCor Medical Recent Development
Table 56. Sonivies Company Detail
Table 57. Sonivies Business Overview
Table 58. Sonivies Hypertension RDN Therapy Product
Table 59. Sonivies Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 60. Sonivies Recent Development
Table 61. Covidien Company Detail
Table 62. Covidien Business Overview
Table 63. Covidien Hypertension RDN Therapy Product
Table 64. Covidien Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 65. Covidien Recent Development
Table 66. Boston Scientific Company Detail
Table 67. Boston Scientific Business Overview
Table 68. Boston Scientific Hypertension RDN Therapy Product
Table 69. Boston Scientific Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 70. Boston Scientific Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Hypertension RDN Therapy Product
Table 74. Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Terumo Corporation Company Detail
Table 77. Terumo Corporation Business Overview
Table 78. Terumo Corporation Hypertension RDN Therapy Product
Table 79. Terumo Corporation Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 80. Terumo Corporation Recent Development
Table 81. Angiocare Company Detail
Table 82. Angiocare Business Overview
Table 83. Angiocare Hypertension RDN Therapy Product
Table 84. Angiocare Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 85. Angiocare Recent Development
Table 86. Shanghai Golden Leaf Med Tec Company Detail
Table 87. Shanghai Golden Leaf Med Tec Business Overview
Table 88. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product
Table 89. Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 90. Shanghai Golden Leaf Med Tec Recent Development
Table 91. Shanghai Bio-Heart Biological Technology Company Detail
Table 92. Shanghai Bio-Heart Biological Technology Business Overview
Table 93. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product
Table 94. Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 95. Shanghai Bio-Heart Biological Technology Recent Development
Table 96. Xinmai Medical Equipment Company Detail
Table 97. Xinmai Medical Equipment Business Overview
Table 98. Xinmai Medical Equipment Hypertension RDN Therapy Product
Table 99. Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 100. Xinmai Medical Equipment Recent Development
Table 101. Microport Ep Medtech Company Detail
Table 102. Microport Ep Medtech Business Overview
Table 103. Microport Ep Medtech Hypertension RDN Therapy Product
Table 104. Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 105. Microport Ep Medtech Recent Development
Table 106. Cryofocus Medtech Company Detail
Table 107. Cryofocus Medtech Business Overview
Table 108. Cryofocus Medtech Hypertension RDN Therapy Product
Table 109. Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2019-2024) & (US$ Million)
Table 110. Cryofocus Medtech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension RDN Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hypertension RDN Therapy Market Share by Type: 2023 VS 2030
Figure 3. r-Renal Denervation(rRDN) Features
Figure 4. u-Renal Denervation(uRDN) Features
Figure 5. Global Hypertension RDN Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Hypertension RDN Therapy Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Hypertension RDN Therapy Report Years Considered
Figure 11. Global Hypertension RDN Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Hypertension RDN Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hypertension RDN Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global Hypertension RDN Therapy Market Share by Players in 2023
Figure 15. Global Top Hypertension RDN Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Hypertension RDN Therapy Revenue in 2023
Figure 17. North America Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Hypertension RDN Therapy Market Share by Country (2019-2030)
Figure 19. United States Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hypertension RDN Therapy Market Share by Country (2019-2030)
Figure 23. Germany Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hypertension RDN Therapy Market Share by Region (2019-2030)
Figure 31. China Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hypertension RDN Therapy Market Share by Country (2019-2030)
Figure 39. Mexico Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hypertension RDN Therapy Market Share by Country (2019-2030)
Figure 43. Turkey Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Hypertension RDN Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 46. ReCor Medical Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 47. Sonivies Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 48. Covidien Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 49. Boston Scientific Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 51. Terumo Corporation Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 52. Angiocare Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 53. Shanghai Golden Leaf Med Tec Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 54. Shanghai Bio-Heart Biological Technology Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 55. Xinmai Medical Equipment Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 56. Microport Ep Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 57. Cryofocus Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
